Clinical Trial Update: Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating riluzole in combination with mFOLFOX6 and bevacizumab for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Riluzole (riluzole)

Snippet

Sponsor: Ning Jin | Conditions: Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 1 | Status: COMPLETED